RUFINAMIDE
ANTICONVULSANTS · LENNOX-GASTAUT EPILEPSY
GLENMARK PHARMA
Drug class
Anticonvulsant - Triazole Derivatives
Anticonvulsant triazole derivatives are a chemically distinct class of antiepileptic agents defined by a five-membered heterocyclic triazole ring, represented clinically by rufinamide. Read more about Anticonvulsant - Triazole Derivatives
13 drugs in this class 12 manufacturers
Drugs in Anticonvulsant - Triazole Derivatives
RUFINAMIDE
ANTICONVULSANTS · LENNOX-GASTAUT EPILEPSY
BIONPHARMA INC.
RUFINAMIDE
ANTICONVULSANTS · LENNOX-GASTAUT EPILEPSY
Hikma Pharmaceuticals USA
RUFINAMIDE
ANTICONVULSANTS · LENNOX-GASTAUT EPILEPSY
NOVADOZ PHARMAC
Filter & compare in the drug finder →
Opens the drug finder with Anticonvulsant - Triazole Derivatives preselected. Add indication or manufacturer filters there.
Anticonvulsant triazole derivatives are a chemically distinct class of antiepileptic agents defined by a five-membered heterocyclic triazole ring, represented clinically by rufinamide.
These agents primarily exert their anticonvulsant effects by modulating voltage-gated sodium channels, specifically prolonging their inactivated state to suppress high-frequency, repetitive neuronal firing without significantly altering normal baseline transmission.
Within clinical neurology, this class is primarily utilized as adjunctive pharmacotherapy in the management of severe, drug-resistant seizure disorders, most notably Lennox-Gastaut syndrome, as well as refractory focal-onset seizures.
-
nih.gov
Anticonvulsant triazole derivatives are a chemically distinct class of antiepileptic agents defined by a five-membered heterocyclic triazole ring, represented clinically by rufinamide
-
nih.gov
Anticonvulsant triazole derivatives are a chemically distinct class of antiepileptic agents defined by a five-membered heterocyclic triazole ring, represented clinically by rufinamide
-
nih.gov
These agents primarily exert their anticonvulsant effects by modulating voltage-gated sodium channels, specifically prolonging their inactivated state to suppress high-frequency, repetitive neuronal firing without significantly altering normal baseline transmission
-
nih.gov
These agents primarily exert their anticonvulsant effects by modulating voltage-gated sodium channels, specifically prolonging their inactivated state to suppress high-frequency, repetitive neuronal firing without significantly altering normal baseline transmission Within clinical neurology, this class is primarily utilized as adjunctive pharmacotherapy in the management of severe, drug-resistant seizure disorders, most notably Lennox-Gastaut syndrome, as well as refractory focal-onset seizures
-
nih.gov
These agents primarily exert their anticonvulsant effects by modulating voltage-gated sodium channels, specifically prolonging their inactivated state to suppress high-frequency, repetitive neuronal firing without significantly altering normal baseline transmission
-
nih.gov
Within clinical neurology, this class is primarily utilized as adjunctive pharmacotherapy in the management of severe, drug-resistant seizure disorders, most notably Lennox-Gastaut syndrome, as well as refractory focal-onset seizures
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.